1.Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)
Nam Hoon KIM ; Juneyoung LEE ; Suk CHON ; Jae Myung YU ; In-Kyung JEONG ; Soo LIM ; Won Jun KIM ; Keeho SONG ; Ho Chan CHO ; Hea Min YU ; Kyoung-Ah KIM ; Sang Soo KIM ; Soon Hee LEE ; Chong Hwa KIM ; Soo Heon KWAK ; Yong‐ho LEE ; Choon Hee CHUNG ; Sihoon LEE ; Heung Yong JIN ; Jae Hyuk LEE ; Gwanpyo KOH ; Sang-Yong KIM ; Jaetaek KIM ; Ju Hee LEE ; Tae Nyun KIM ; Hyun Jeong JEON ; Ji Hyun LEE ; Jae-Han JEON ; Hye Jin YOO ; Hee Kyung KIM ; Hyeong-Kyu PARK ; Il Seong NAM-GOONG ; Seongbin HONG ; Chul Woo AHN ; Ji Hee YU ; Jong Heon PARK ; Keun-Gyu PARK ; Chan Ho PARK ; Kyong Hye JOUNG ; Ohk-Hyun RYU ; Keun Yong PARK ; Eun-Gyoung HONG ; Bong-Soo CHA ; Kyu Chang WON ; Yoon-Sok CHUNG ; Sin Gon KIM
Endocrinology and Metabolism 2024;39(5):722-731
		                        		
		                        			 Background:
		                        			Atherogenic dyslipidemia, which is frequently associated with type 2 diabetes (T2D) and insulin resistance, contributes to the development of vascular complications. Statin therapy is the primary approach to dyslipidemia management in T2D, however, the role of non-statin therapy remains unclear. Ezetimibe reduces cholesterol burden by inhibiting intestinal cholesterol absorption. Fibrates lower triglyceride levels and increase high-density lipoprotein cholesterol (HDL-C) levels via peroxisome proliferator- activated receptor alpha agonism. Therefore, when combined, these drugs effectively lower non-HDL-C levels. Despite this, few clinical trials have specifically targeted non-HDL-C, and the efficacy of triple combination therapies, including statins, ezetimibe, and fibrates, has yet to be determined. 
		                        		
		                        			Methods:
		                        			This is a multicenter, prospective, randomized, open-label, active-comparator controlled trial involving 3,958 eligible participants with T2D, cardiovascular risk factors, and elevated non-HDL-C (≥100 mg/dL). Participants, already on moderate-intensity statins, will be randomly assigned to either Ezefeno (ezetimibe/fenofibrate) addition or statin dose-escalation. The primary end point is the development of a composite of major adverse cardiovascular and diabetic microvascular events over 48 months. 
		                        		
		                        			Conclusion
		                        			This trial aims to assess whether combining statins, ezetimibe, and fenofibrate is as effective as, or possibly superior to, statin monotherapy intensification in lowering cardiovascular and microvascular disease risk for patients with T2D. This could propose a novel therapeutic approach for managing dyslipidemia in T2D. 
		                        		
		                        		
		                        		
		                        	
2.Quality of Acute Stroke Care within Emergency Medical Service System in Korea: Proposal for Severe Emergency Medical Center
Kyung Bok LEE ; Ji Sung LEE ; Jeong-Yoon LEE ; Jun Yup KIM ; Han-Yeong JEONG ; Seong-Eun KIM ; Jonguk KIM ; Do Yeon KIM ; Keon-Joo LEE ; Jihoon KANG ; Beom Joon KIM ; Tae Jung KIM ; Sang Joon AN ; Jang-Hyun BAEK ; Seongheon KIM ; Hyun-Wook NAH ; Jong Yun LEE, ; Jee-Hyun KWON ; Seong Hwan AHN ; Keun-Hwa JUNG ; Hee-Kwon PARK ; Tai Hwan PARK ; Jong-Moo PARK ; Yong-Jin CHO ; Im Seok KOH ; Soo Joo LEE ; Jae-Kwan CHA ; Joung-Ho RHA ; Juneyoung LEE ; Boung Chul LEE ; In Ok BAE ; Gui Ok KIM ; Hee-Joon BAE
Journal of the Korean Neurological Association 2023;41(1):18-30
		                        		
		                        			 Background:
		                        			Korea recently established 70 emergency medical service areas. However, there are many concerns that medical resources for stroke could not be evenly distributed through the country. We aimed to compare the treatment quality and outcomes of acute stroke among the emergency medical service areas. 
		                        		
		                        			Methods:
		                        			This study analyzed the data of 28,800 patients admitted in 248 hospitals which participated in the 8th acute stroke quality assessment by Health Insurance Review and Assessment Service. Individual hospitals were regrouped into emergency service areas according to the address of the location. Assessment indicators and fatality were compared by the service areas. We defined the appropriate hospital by the performance of intravenous thrombolysis. 
		                        		
		                        			Results:
		                        			In seven service areas, there were no hospitals which received more than 10 stroke patients for 6 months. In nine service areas, there were no patients who underwent intravenous thrombolysis (IVT). Among 167 designated emergency medical centers, 50 hospitals (29.9%) responded that IVT was impossible 24 hours a day. There are 97 (39.1%) hospitals that meet the definitions of appropriate hospital. In 23 service areas (32.9%) had no appropriate or feasible hospitals. The fatality of service areas with stroke centers were 6.9% within 30 days and 15.6% within 1 year from stroke onset than those without stroke centers (7.7%, 16.9%, respectively). 
		                        		
		                        			Conclusions
		                        			There was a wide regional gap in the medical resource and the quality of treatments for acute stroke among emergency medical service areas in Korea. The poststroke fatality rate of the service areas which have stroke centers or appropriate hospitals were significantly low. 
		                        		
		                        		
		                        		
		                        	
3.2022 Update of the Korean Clinical Practice Guidelines for Stroke: Antithrombotic Therapy for Patients with Acute Ischemic Stroke or Transient Ischemic Attack
Hong-Kyun PARK ; Sang-Bae KO ; Keun-Hwa JUNG ; Min Uk JANG ; Dae-Hyun KIM ; Joon-Tae KIM ; Jay Chol CHOI ; Hye Seon JEONG ; Chulho KIM ; Ji Hoe HEO ; Joung-Ho RHA ; Sun U. KWON ; Jong S. KIM ; Byung-Chul LEE ; Hee-Joon BAE ; Byung-Woo YOON ; Keun-Sik HONG
Journal of Stroke 2022;24(1):166-175
		                        		
		                        			
		                        			 Antithrombotic therapy is a cornerstone of acute ischemic stroke (AIS) management and secondary stroke prevention. Since the first version of the Korean Clinical Practice Guideline (CPG) for stroke was issued in 2009, significant progress has been made in antithrombotic therapy for patients with AIS, including dual antiplatelet therapy in acute minor ischemic stroke or high-risk transient ischemic stroke and early oral anticoagulation in AIS with atrial fibrillation. The evidence is widely accepted by stroke experts and has changed clinical practice. Accordingly, the CPG Committee of the Korean Stroke Society (KSS) decided to update the Korean Stroke CPG for antithrombotic therapy for AIS. The writing members of the CPG committee of the KSS reviewed recent evidence, including clinical trials and relevant literature, and revised recommendations. A total of 35 experts were invited from the KSS to reach a consensus on the revised recommendations. The current guideline update aims to assist healthcare providers in making well-informed decisions and improving the quality of acute stroke care. However, the ultimate treatment decision should be made using a holistic approach, considering the specific medical conditions of individual patients. 
		                        		
		                        		
		                        		
		                        	
4.A Case of Livedoid Vasculopathy Successfully Treated with Sulodexide
Chang Hwa SONG ; Dong Seok SHIN ; Ju Wang JANG ; Tae Lim KIM ; Young Gyun KIM ; Joung Soo KIM ; Hyun-Min SEO
Annals of Dermatology 2020;32(6):508-511
		                        		
		                        			
		                        			 We report a 29-year-old female with a one-month history of non-healing multiple erythematous to violaceous plaques with crusts over both legs and feet. Tender, scarring ulcers with surrounding erythema were present. The clinical manifestation, together with histopathologic findings of fibrinoid plugs within vascular lumens and walls, as well as red blood cell extravasation, led to diagnosis of livedoid vasculopathy.The patient experienced recurrent painful violaceous plaques with ulcerations during the two years of treatment with oral pentoxifylline 400 mg three times daily. The cutaneous lesions and symptoms dramatically improved after the treatment regimen changed to oral sulodexide (250 lipasemic units) three times daily. Sulodexide, a highly purified mixture of glycosaminoglycans including dermatan sulfate and lowmolecular weight heparin, could be an effective therapy for recalcitrant livedoid vasculopathy. Herein, we report a case of livedoid vasculopathy treated with sulodexide, which has not previously been reported. 
		                        		
		                        		
		                        		
		                        	
5.The Brain Donation Program in South Korea.
Yeshin KIM ; Yeon Lim SUH ; Seung Joo KIM ; Moon Hwan BAE ; Jae Bum KIM ; Yuna KIM ; Kyung Chan CHOI ; Gi Yeong HUH ; Eun Joo KIM ; Jung Seok LEE ; Hyun Wook KANG ; Sung Mi SHIM ; Hyun Joung LIM ; Young Ho KOH ; Byeong Chae KIM ; Kyung Hwa LEE ; Min Cheol LEE ; Ho Won LEE ; Tae Sung LIM ; William W. SEELEY ; Hee Jin KIM ; Duk L. NA ; Kyung Hoon LEE ; Sang Won SEO
Yonsei Medical Journal 2018;59(10):1197-1204
		                        		
		                        			
		                        			PURPOSE: Obtaining brain tissue is critical to definite diagnosis and to furthering understanding of neurodegenerative diseases. The present authors have maintained the National Neuropathology Reference and Diagnostic Laboratories for Dementia in South Korea since 2016. We have built a nationwide brain bank network and are collecting brain tissues from patients with neurodegenerative diseases. We are aiming to facilitate analyses of clinic-pathological and image-pathological correlations of neurodegenerative disease and to broaden understanding thereof. MATERIALS AND METHODS: We recruited participants through two routes: from memory clinics and the community. As a baseline evaluation, clinical interviews, a neurological examination, laboratory tests, neuropsychological tests, and MRI were undertaken. Some patients also underwent amyloid PET. RESULTS: We recruited 105 participants, 70 from clinics and 35 from the community. Among them, 11 died and were autopsied. The clinical diagnoses of the autopsied patients included four with Alzheimer's disease (AD), two with subcortical vascular dementia, two with non-fluent variant primary progressive aphasia, one with leukoencephalopathy, one with frontotemporal dementia (FTD), and one with Creutzfeldt-Jakob disease (CJD). Five patients underwent amyloid PET: two with AD, one with mixed dementia, one with FTD, and one with CJD. CONCLUSION: The clinical and neuropathological information to be obtained from this cohort in the future will provide a deeper understanding of the neuropathological mechanisms of cognitive impairment in Asia, especially Korea.
		                        		
		                        		
		                        		
		                        			Alzheimer Disease
		                        			;
		                        		
		                        			Amyloid
		                        			;
		                        		
		                        			Aphasia, Primary Progressive
		                        			;
		                        		
		                        			Asia
		                        			;
		                        		
		                        			Brain*
		                        			;
		                        		
		                        			Cognition Disorders
		                        			;
		                        		
		                        			Cohort Studies
		                        			;
		                        		
		                        			Creutzfeldt-Jakob Syndrome
		                        			;
		                        		
		                        			Dementia
		                        			;
		                        		
		                        			Dementia, Vascular
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Frontotemporal Dementia
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea*
		                        			;
		                        		
		                        			Leukoencephalopathies
		                        			;
		                        		
		                        			Magnetic Resonance Imaging
		                        			;
		                        		
		                        			Memory
		                        			;
		                        		
		                        			Neurodegenerative Diseases
		                        			;
		                        		
		                        			Neurologic Examination
		                        			;
		                        		
		                        			Neuropathology
		                        			;
		                        		
		                        			Neuropsychological Tests
		                        			
		                        		
		                        	
6.Utility of Susceptibility-Weighted Imaging in Comatose Patients after Cardiac Arrest: A Preliminary Study.
Jin Tae HWANG ; Yong Hwan KIM ; Jun Ho LEE ; Kwang Won CHO ; Mun Ju KANG ; Dong Woo LEE ; Yun Gyu SONG ; Jung Min KIM ; Joung Hun BYUN ; Seong Youn HWANG ; Jung Hwa LEE
Journal of the Korean Society of Emergency Medicine 2017;28(5):441-448
		                        		
		                        			
		                        			PURPOSE: This study was conducted to examine the efficacies of susceptibility weighted images (SWI) for predicting the clinical prognosis of comatose patients following cardiac arrest. METHODS: Thirty-two patients who were resuscitated from cardiac arrest and underwent brain magnetic resonance imaging (MRI) were retrospectively investigated and compared to 32 subjects with normal brain MRI findings who served as controls. The SWI readings were divided into three categories: prominent, diminished, and normal. Comatose patients were divided into two groups: those with a Glasgow-Pittsburgh cerebral performance category (CPC) of 1-2 (good outcome group) and those with a CPC of 3-5 (poor outcome group). RESULTS: Of the 32 patients, 17 (53.1%) showed good neurological outcomes upon hospital discharge. Normal patterns on SWI were mainly seen in the good outcome group (15 patients, 88.2%), while diminished patterns and prominent patterns were frequently found in the poor outcome group (13 patients, 88.7%). The combination of diminished pattern and prominent pattern predicted poor outcome with 86.7% sensitivity (95% confidence interval, 69.5%-100%) and 88.2% specificity (95% confidence interval, 72.9%-100%). CONCLUSION: The SWI findings correlate with the outcome of hypoxic-ischemic encephalopathy and may be a useful adjunct of vegetative state or death in comatose patients after cardiac arrest.
		                        		
		                        		
		                        		
		                        			Brain
		                        			;
		                        		
		                        			Coma*
		                        			;
		                        		
		                        			Heart Arrest*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypoxia-Ischemia, Brain
		                        			;
		                        		
		                        			Magnetic Resonance Imaging
		                        			;
		                        		
		                        			Persistent Vegetative State
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Reading
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Sensitivity and Specificity
		                        			
		                        		
		                        	
7.The Effect of an Upper Limb Rehabilitation Robot on Hemispatial Neglect in Stroke Patients.
Yoon Sik CHOI ; Kyeong Woo LEE ; Jong Hwa LEE ; Sang Beom KIM ; Gyu Tae PARK ; Sook Joung LEE
Annals of Rehabilitation Medicine 2016;40(4):611-619
		                        		
		                        			
		                        			OBJECTIVE: To investigate the effectiveness of an upper limb rehabilitation robot therapy on hemispatial neglect in stroke patients. METHODS: Patients were randomly divided into an upper limb rehabilitation robot treatment group (robot group) and a control group. The patients in the robot group received left upper limb training using an upper limb rehabilitation robot. The patients sat on the right side of the robot, so that the monitor of the robot was located on the patients' left side. In this position, patients could focus continuously on the left side. The control group received conventional neglect treatment, such as visual scanning training and range of motion exercises, administered by occupational therapists. Both groups received their respective therapies for 30 minutes a day, 5 days a week for 3 weeks. Several tests were used to evaluate treatment effects before and after the 3-week treatment. RESULTS: In total, 38 patients (20 in the robot group and 18 in the control group) completed the study. After completion of the treatment sessions, both groups showed significant improvements in the Motor-Free Visual Perception Test 3rd edition (MVPT-3), the line bisection test, the star cancellation test, the Albert's test, the Catherine Bergego scale, the Mini-Mental State Examination and the Korean version of Modified Barthel Index. The changes in all measurements showed no significant differences between the two groups. CONCLUSION: This present study showed that the upper limb robot treatment had benefits for hemispatial neglect in stroke patients that were similar to conventional neglect treatment. The upper limb robot treatment could be a therapeutic option in the treatment of hemispatial neglect after stroke.
		                        		
		                        		
		                        		
		                        			Exercise
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Perceptual Disorders*
		                        			;
		                        		
		                        			Range of Motion, Articular
		                        			;
		                        		
		                        			Rehabilitation*
		                        			;
		                        		
		                        			Robotics
		                        			;
		                        		
		                        			Stroke*
		                        			;
		                        		
		                        			Upper Extremity*
		                        			;
		                        		
		                        			Visual Perception
		                        			
		                        		
		                        	
8.Endoluminal Closure of Colon Perforation with Endoscopic Band Ligation: Technical Feasibility and Safety in an In Vivo Canine Model.
Joung Ho HAN ; Myounghwan KIM ; Tae Hoon LEE ; Hyun KIM ; Yunho JUNG ; Seon Mee PARK ; Heebok CHAE ; Seijin YOUN ; Ji Yun SHIN ; In Kwang LEE ; Tae Soo LEE ; Seok Hwa CHOI
Clinical Endoscopy 2015;48(6):534-541
		                        		
		                        			
		                        			BACKGROUND/AIMS: Endoscopic band ligation (EBL) is an accepted method in the management of variceal bleeding; however, there is little evidence on the safety and feasibility of EBL for the closure of bowel perforation. In this study, we aimed to evaluate the technical feasibility and efficacy of EBL in iatrogenic colon perforation by using a canine model. METHODS: We established an iatrogenic colon perforation model by using seven beagle dogs. Longitudinal 1.5- to 1.7-cm colon perforations were created with a needle knife and an insulated-tip knife, and the perforation was subsequently closed with EBL. During a 2-week follow-up period, the animals were carefully monitored and then euthanized for pathologic examination. RESULTS: The EBL of iatrogenic colon perforations was successful in all dogs. The mean procedure time for EBL closure with one to three bands was 191.7 seconds, and there were no immediate complications. One animal was euthanized after 3 days because of peritonitis. There were no clinical and laboratory features of sepsis or peritonitis in the remaining six animals. On necropsy, we did not find any fecal peritonitis, pericolonic abscess formation, or transmural dehiscence at the perforation site. Histopathology demonstrated inflamed granulation tissue and scar lesions replaced by fibrosis. CONCLUSIONS: EBL might be a feasible and safe method for the management of iatrogenic colon perforations in an in vivo model.
		                        		
		                        		
		                        		
		                        			Abscess
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Cicatrix
		                        			;
		                        		
		                        			Colon*
		                        			;
		                        		
		                        			Dogs
		                        			;
		                        		
		                        			Esophageal and Gastric Varices
		                        			;
		                        		
		                        			Fibrosis
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Granulation Tissue
		                        			;
		                        		
		                        			Ligation*
		                        			;
		                        		
		                        			Needles
		                        			;
		                        		
		                        			Peritonitis
		                        			;
		                        		
		                        			Sepsis
		                        			
		                        		
		                        	
9.Occurrence of colonic liposarcoma after retroperitoneal liposarcoma.
Jin Hwa CHOI ; In Gyu HWANG ; Seong Jae CHA ; Tae Jin LEE ; Joung Soon JANG
The Korean Journal of Internal Medicine 2015;30(1):125-128
		                        		
		                        			
		                        			No abstract available.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Biopsy
		                        			;
		                        		
		                        			Chemotherapy, Adjuvant
		                        			;
		                        		
		                        			Colectomy
		                        			;
		                        		
		                        			Colonic Neoplasms/*pathology/therapy
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Liposarcoma/*pathology/therapy
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Neoplasms, Second Primary/*pathology/therapy
		                        			;
		                        		
		                        			Radiotherapy, Adjuvant
		                        			;
		                        		
		                        			Retroperitoneal Neoplasms/*pathology/therapy
		                        			;
		                        		
		                        			Time Factors
		                        			;
		                        		
		                        			Tomography, X-Ray Computed
		                        			;
		                        		
		                        			Treatment Outcome
		                        			
		                        		
		                        	
10.Differential Expression of E-Cadherin, beta-Catenin, and S100A4 in Intestinal Type and Nonintestinal Type Ampulla of Vater Cancers.
Rohyun SUNG ; Li KANG ; Joung Ho HAN ; Jae Woon CHOI ; Sang Hwa LEE ; Tae Hoon LEE ; Sang Heum PARK ; Hong Ja KIM ; Eaum Seok LEE ; Young Suk KIM ; Young Woo CHOI ; Seon Mee PARK
Gut and Liver 2014;8(1):94-101
		                        		
		                        			
		                        			BACKGROUND/AIMS: Epithelial-mesenchymal transition (EMT)-related proteins may exhibit differential expression in intestinal type or pancreatobiliary type ampulla of Vater carcinomas (AVCs). We evaluated the expression of E-cadherin, beta-catenin, and S100A4 in intestinal and nonintestinal type AVCs and analyzed their relationships with clinicopathological variables and survival. METHODS: A clinicopathological review of 105 patients with AVCs and immunohistochemical staining for E-cadherin, beta-catenin, and S100A4 were performed. The association between clinicopathological parameters, histological type, and expression of EMT proteins and their effects on survival were analyzed. RESULTS: Sixty-five intestinal type, 35 pancreatobiliary type, and five other types of AVCs were identified. The severity of EMT changes differed between the AVC types; membranous loss of E-cadherin and beta-catenin was observed in nonintestinal type tumors, whereas aberrant nonmembranous beta-catenin expression was observed in intestinal type tumors. EMT-related changes were more pronounced in the invasive tumor margin than in the tumor center, and these EMT-related changes were related to tumor aggressiveness. Among the clinicopathological parameters, a desmoplastic reaction was related to overall survival, and the reaction was more severe in nonintestinal type than in intestinal type AVCs. CONCLUSIONS: Dysregulation of E-cadherin, beta-cadherin, and S100A4 expression may play a role in the carcinogenesis and tumor progression of AVCs.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Aged, 80 and over
		                        			;
		                        		
		                        			Ampulla of Vater/*metabolism
		                        			;
		                        		
		                        			Cadherins/metabolism
		                        			;
		                        		
		                        			Common Bile Duct Neoplasms/classification/*metabolism
		                        			;
		                        		
		                        			Disease-Free Survival
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			S100 Proteins/metabolism
		                        			;
		                        		
		                        			Tumor Markers, Biological/*metabolism
		                        			;
		                        		
		                        			beta Catenin/metabolism
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail